Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Human Reproduction (Oxford, England)|December 9, 2016
The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional studyPanagiotis Drakopoulos, Arne van de Vijver, Valerie Schutyser, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 13, 2018
Does the type of GnRH analogue used, affect live birth rates in women with endometriosis undergoing IVF/ICSI treatment, according to the rAFS stage?Panagiotis Drakopoulos, Jérôme Rosetti, Nicola Pluchino, et al.
Reproductive Biomedicine Online|July 17, 2012
Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized studyDimitra Kyrou, Efstratios M Kolibianakis, Human M Fatemi, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 15, 2015
Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian respondersNikolaos P Polyzos, Roberta Corona, Arne Van De Vijver, et al.
Reproductive Biology and Endocrinology : RB&E|February 20, 2021
Improved clinical outcomes after non-invasive oocyte selection and Day 3 eSET in ICSI patientsInge Van Vaerenbergh, Tom Adriaenssens, Wim Coucke, et al.
Plos One|January 31, 2024
Non-invasive cumulus cell analysis can be applied for oocyte ranking and is useful for countries with legal restrictions on embryo generation or freezingTom Adriaenssens, Inge Van Vaerenbergh, Lisbet Van Landuyt, et al.
Human Reproduction (Oxford, England)|October 18, 2017
Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trialPanagiotis Drakopoulos, Thi Ngoc Lan Vuong, Ngoc Anh Vu Ho, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 11, 2012
ÉquiNanos: innovative team for nanoparticle risk managementSylvie Nadeau, Michèle Bouchard, Maximilien Debia, et al.
Pageof 7